Host: |
Rabbit |
Applications: |
IHC |
Reactivity: |
Human/Mouse |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-ASB4 (1-300) is suitable for use in Immunohistochemistry research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
PBS with 0.01% Thimerosal, 50% Glycerol, pH7.3. |
Purification: |
Affinity purification |
Dilution Range: |
IHC-P 1:50-1:200 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
ASB4 |
Gene ID: |
51666 |
Uniprot ID: |
ASB4_HUMAN |
Immunogen Region: |
1-300 |
Immunogen: |
Recombinant fusion protein containing a sequence corresponding to amino acids 1-300 of human ASB4 (NP_665879.1). |
Immunogen Sequence: |
MDGTTAPVTKSGAAKLVKRN FLEALKSNDFGKLKAILIQR QIDVDTVFEVEDENMVLASY KQGYWLPSYKLKSSWATGLH LSVLFGHVECLLVLLDHNAT INCRPNGKTPLHVACEMANV DCVKILCDRGAKLNCYSLSG HTALHFCTTPSSILCAKQLV WRGANVNMKTNNQDEETPLH TAAHFGLSELVAFYVEHGAI VDSVNAHMETPLAIAAYWAL RFKEQEYSTEHHLVCRMLL |
Post Translational Modifications | Hydroxylation at Asn-246 by HIF1AN may provide an oxygen-dependent regulation mechanism for the function of ASB4 in promoting vascular differentiation. |
Function | Probable substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. Promotes differentiation and maturation of the vascular lineage by an oxygen-dependent mechanism. |
Protein Name | Ankyrin Repeat And Socs Box Protein 4Asb-4 |
Database Links | Reactome: R-HSA-8951664Reactome: R-HSA-983168 |
Alternative Antibody Names | Anti-Ankyrin Repeat And Socs Box Protein 4 antibodyAnti-Asb-4 antibodyAnti-ASB4 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance